Search for: "Ely Lilly"
Results 1541 - 1560
of 2,157
Sorted by Relevance
|
Sort by Date
21 May 2014, 7:41 am
Eli Lilly & Co., 592 F.2d 317, 319 (6th Cir. 1979) (“This is not the first time our questions have been rebuffed by the Michigan Supreme Court . . . . [read post]
29 Feb 2024, 5:17 pm
On April 14, 2023, the PTO issued an ORDER TO SHOW CAUSE to Eli Lilly and Company (“Lilly”) “based on the apparent ineligibility of U.S. [read post]
20 Sep 2009, 7:38 am
The job cuts will reduce Eli Lilly's work force by approximately 14%. [read post]
23 Feb 2011, 9:49 am
Eli Lilly & Co., 598 F.3d 1336, 1354 (Fed. [read post]
11 Dec 2023, 7:43 am
” citing Eli Lilly and Co. v. [read post]
31 Mar 2016, 6:40 am
" Dr Peters, who also writes a column for Medscape Diabetes & Endocrinology, has served as a speaker or consultant with Eli Lilly, Boehringer Ingelheim Pharmaceuticals, and AstraZeneca Pharmaceuticals, which make SGLT-2 inhibitors. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole)… [read post]
15 Feb 2007, 1:02 pm
A US District Court judge today refused Eli Lilly's request to ban a number of websites from publishing leaked documents relating to Zyprexa, Eli Lilly's top-selling drug. [read post]
3 Apr 2017, 1:00 am
On Tuesday 4 April until Thursday 6 April, the Supreme Court will hear the appeal of Eli Lilly & Co v Actavis UK Ltd & Ors, and other cases. [read post]
9 Sep 2010, 7:09 pm
See Eli Lilly, 471 F.3d at 1377-79. [read post]
18 Jan 2016, 7:44 am
Eli Lilly and Co., January 13, 2016, Van Antwerpen, F.). [read post]
13 Sep 2010, 12:58 pm
Eli Lilly Canada Inc. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell… [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly… [read post]
5 Sep 2017, 2:30 pm
Recently, Judge Seeborg expanded the MDL proceedings to include claims against Eli Lilly & Company, after patients who ingested Cialis (a drug similar to Viagra) also developed melanoma. [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
9 Oct 2011, 4:35 pm
Merck, Johnson & Johnson, Eli Lilly and Bristol-Myers Squibb also cut jobs. [read post]
14 Jun 2007, 12:57 am
Eli Lilly: Lawyers' Ads Are Hurting Patients
The Associated Press
Eli Lilly and Co., which has faced thousands of suits over its anti-psychotic Zyprexa, says lawyers' ads about the drug are prompting patients to stop taking mental illness medications when they shouldn't. [read post]
5 Mar 2024, 10:55 am
For example, Novo Nordisk has issued three notices of correction for Ozempic since 2022; Eli Lilly has issued five for Cialis and six for Strattera since 2021. [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint… [read post]
